SLIT2 and myelodysplastic syndrome: ROBO mutations lead to the inactivation of ROBO-SLIT2 signalling, and relieved the depressive effect on the AKT/GSK3/β-catenin pathway, which can result in uncontrolled cell proliferation and thus disease progression in MDS.